PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.45%
Negative revenue growth while QCOM stands at 20.71%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-33.23%
Negative gross profit growth while QCOM is at 28.83%. Joel Greenblatt would examine cost competitiveness or demand decline.
-87.40%
Negative EBIT growth while QCOM is at 62.14%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.30%
Negative operating income growth while QCOM is at 62.14%. Joel Greenblatt would press for urgent turnaround measures.
-80.99%
Negative net income growth while QCOM stands at 17.38%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-79.07%
Negative EPS growth while QCOM is at 13.04%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-79.07%
Negative diluted EPS growth while QCOM is at 15.56%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.76%
Share reduction while QCOM is at 1.48%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.28%
Reduced diluted shares while QCOM is at 1.45%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
9.57%
Dividend growth above 1.5x QCOM's 0.43%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
6.27%
OCF growth under 50% of QCOM's 33.92%. Michael Burry might suspect questionable revenue recognition or rising costs.
21.75%
FCF growth under 50% of QCOM's 211.89%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
121.43%
10Y revenue/share CAGR at 75-90% of QCOM's 146.47%. Bill Ackman would press for new markets or product lines to narrow the gap.
81.93%
5Y revenue/share CAGR under 50% of QCOM's 251.51%. Michael Burry would suspect a significant competitive gap or product weakness.
-13.17%
Negative 3Y CAGR while QCOM stands at 111.25%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
367.14%
10Y OCF/share CAGR 1.25-1.5x QCOM's 331.06%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
111.98%
5Y OCF/share CAGR 1.25-1.5x QCOM's 80.03%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
54.17%
3Y OCF/share CAGR above 1.5x QCOM's 3.72%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
0.30%
Below 50% of QCOM's 1405.68%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-57.80%
Negative 5Y net income/share CAGR while QCOM is 188.71%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-79.55%
Negative 3Y CAGR while QCOM is 61.42%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
153.14%
Below 50% of QCOM's 1182.69%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
59.03%
Below 50% of QCOM's 126.28%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-2.17%
Negative 3Y equity/share growth while QCOM is at 59.62%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
656.97%
Dividend/share CAGR of 656.97% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
692.36%
5Y dividend/share CAGR above 1.5x QCOM's 357.03%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
267.82%
3Y dividend/share CAGR above 1.5x QCOM's 78.98%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-48.53%
Firm’s AR is declining while QCOM shows 340.35%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-12.70%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-4.36%
Negative asset growth while QCOM invests at 25.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.95%
We have a declining book value while QCOM shows 5.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-14.99%
Our R&D shrinks while QCOM invests at 4.19%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.18%
We cut SG&A while QCOM invests at 0.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.